주식 시장 뉴스
최신 금융 뉴스 · 업데이트 7월 26, 2026
Uniti Group Inc. 2026년 1분기 실적 발표 요약
Uniti Group Inc. Q1 2026 Earnings Call Summary
Panelists agree on Uniti's (UNIT) ambitious fiber expansion plan, but disagree on its feasibility and risk profile. Gemini and Grok …
Village Farms International, Inc. 2026년 1분기 실적 발표 요약
Village Farms International, Inc. Q1 2026 Earnings Call Summary
Panelists agree that Village Farms (VFF) has successfully transitioned to a high-margin cannabis exporter, with robust international traction and a …
5월 2026년 매수할 만한 최근 기술 IPO 상위 2개
My Top 2 Recent Tech IPOs to Buy for May 2026
The panel consensus is bearish on both Circle (CRCL) and CoreWeave (CRWV), citing existential regulatory risks, reliance on a few …
Galaxy 지원 Boundary, USBD 스테이블코인 출시 예정
Galaxy-Backed Boundary To Launch USBD Stablecoin
Despite the potential of daily on-chain verification, Boundary Labs' USBD stablecoin faces significant challenges in liquidity, regulatory compliance, and operational …
Radiant Logistics FQ3 기대치 상회
Radiant Logistics beats FQ3 expectations
Despite a clean EPS beat, Radiant Logistics' (RLGT) operational margins eroded significantly, and international headwinds pose substantial risks to its …
'빅 쇼트' 투자자 마이클 버리, 시장이 '샤크 점프'했다 — 투자자들이 잘못 생각하는 것은 무엇이라고 말하는가
'Big Short' investor Michael Burry says the market has 'jumped the shark' — what he says investors are getting wrong
Panelists agree that while the current market has notable concentration risk and high valuations, it may persist due to structural …
차단 Cuts Iovance (IOVA) 가격 목표 하락, Buy 등급 유지
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
While IOVA's Q1 revenue growth is impressive, the panelists have mixed views on its sustainability and profitability. The price target …
Canaccord, Taysha(TSHA) Q1 하이라이트 후 매수 등급 유지
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights
The panelists have mixed views on TSHA's potential. While some see promise in the FDA alignment and the addressable market, …
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
The panelists agree that MannKind's (MNKD) valuation hinges on the success of its royalty streams, particularly from Tyvaso DPI, and …
1명의 월스트리트 최고 분석가가 CRISPR Therapeutics가 두 배 이상 상승할 수 있다고 생각합니다. 주식을 닥치는 대로 사야 할까요?
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
CRISPR Therapeutics' stock performance is driven by optimism around CTX611 and oncology candidates, but faces significant risks including complex manufacturing, …
Geron (GERN)은 매수할 만한 최고의 미국 주식 5달러 미만 중 하나인가?
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
Geron's (GERN) commercial success hinges on RYTELO's adoption curve and potential label expansion. While Q1 2026 revenue of $51.8M shows …
한국전력 1분기 실적 증가
Korea Electric Power Q1 Earnings Rise
The panel consensus is bearish, with all participants expressing concerns about KEP's earnings growth, margin compression, and significant debt servicing …